SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The impact of reference-pricing systems in Europe: a literature review and case studies
16 references·0 citing·40 second hop
The impact of reference-pricing systems in Europe: a literature review and case studies (2011)The impact of reference-pricing systems i…Generic Medicine Pricing Policies in Europe: Current Status and Impact (2010)Generic Medicine Pricing Poli…Effects of Reference Pricing in Pharmaceutical Markets (2010)Effects of Reference Pricing …Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Regulation and pricing of pha…Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004? (2008)Price control as a strategy f…Competition in off-patent drug markets: Issues, regulation and evidence (2008)Competition in off-patent dru…The impact of generic reference pricing interventions in the statin market (2007)The impact of generic referen…Sustaining Generic Medicines Markets in Europe (2006)Sustaining Generic Medicines …Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? (2006)Do policy changes in the phar…Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand (2004)Reference Pricing of Pharmace…Pharmaceutical policy in Italy: towards a structural change? (2004)Pharmaceutical policy in Ital…Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers (2003)Clinical and economic consequ…Reference-Based Pricing Schemes (2002)Reference-Based Pricing Schem…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses? (2002)Do Pharmaceutical Prices Resp…Review of the literature on reference pricing (2000)Review of the literature on r…The German experience in reference pricing (1998)The German experience in refe…Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2014)The Ethics and Economics of Pharmaceutical Pricing (2014)Strategic horizontal integration for drug cost reduction in the pharmaceutical supply chain (2021)The role of economic evaluation in the pricing and reimbursement of medicines (1997)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Federal Republic of Germany (1985)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Free for All? Lessons from the RAND Health Insurance Experiment (1995)Reference pricing of pharmaceuticals (2006)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Impact of European Pharmaceutical Price Regulation on Generic Price Competition (2010)Payment Restrictions for Prescription Drugs under Medicaid (1987)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)The Theory of Industrial Organization (1988)Theory of Industrial Organization. (1989)Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs (2013)Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development (2013)Econometric Analysis of Panel Data (2021)Encouraging the use of generic medicines: implications for transition economies. (2002)Physician Agency and Adoption of Generic Pharmaceuticals (2012)Industrial Market Structure and Economic Performance. (1971)Industrial market structure and economic performance (1990)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field (2009)Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives (1970)Cross-national price differences for pharmaceuticals: how large, and why? (2000)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany (2012)Estimating the Effect of Training Programs on Earnings (1978)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Evaluating the Effect of Teachers’ Group Performance Incentives on Pupil Achievement (2002)Die another day: duration in German import trade (2009)Pricing and reimbursement of in-patent drugs in seven European countries: A comparative analysis (2006)
this work references cited by second hop

References

  • 2000Review of the literature on reference pricing203 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited
  • 2006Sustaining Generic Medicines Markets in Europe161 cited
  • 2008Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?153 cited
  • 2002Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?150 cited
  • 2008Competition in off-patent drug markets: Issues, regulation and evidence140 cited
  • 2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand126 cited
  • 2010Effects of Reference Pricing in Pharmaceutical Markets88 cited
  • 1998The German experience in reference pricing84 cited
  • 2002Reference-Based Pricing Schemes77 cited
  • 2008Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004?71 cited
  • 2010Generic Medicine Pricing Policies in Europe: Current Status and Impact68 cited
  • 2006Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?60 cited
  • 2004Pharmaceutical policy in Italy: towards a structural change?60 cited
  • 2003Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

59 cited
  • 2007The impact of generic reference pricing interventions in the statin market51 cited
  • Cited by

    No citing works inside the corpus for this window.